- Filed
- Oct 16, 2025
- Last modified
- Apr 16, 2026
- Petitioner
- Ontel Products Corporation et al.
- Inventor
- Bruce Cannon et al
Patent RE48479
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (1)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Happy Products, Inc.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
One AIA trial proceeding is on file for US patent RE48479. This proceeding, IPR2025-01536, resulted in a discretionary denial of institution, meaning the patent claims were not reviewed on the merits by the Patent Trial and Appeal Board (PTAB). Consequently, all claims of RE48479 remain untested on their patentability by the PTAB. This gives a defendant facing assertion of this patent the defensive posture that the patent's claims have not been challenged and validated by the PTAB, but the specific petitioner (Ontel Products Corporation et al.) may be estopped from re-raising similar challenges.
IPR2025-01536 — Ontel Products Corporation et al. v. Bruce Cannon et al
- Type: Inter Partes Review
- Filed: 2025-10-16
- Status: Discretionary Denial — The petition for inter partes review was denied institution by the USPTO Director on policy grounds, without a review of the merits of the patentability challenge. The last modification to the case was 2026-04-16.
- Judge panel: During the period this petition was filed and decided, institution decisions for IPRs were handled by the Director of the USPTO, often in consultation with Administrative Patent Judges (APJs), rather than a traditional three-judge panel for a merits review. [cite: 3, 4, 5, 8, 10 in the prior step] The specific Director's decision document would identify any consulting APJs or simply indicate a Director's Decision. Without the specific decision document, the names of consulting APJs (if any) are not publicly available.
- Petition grounds: The specific claims challenged and the prior art cited are not publicly available without the petition document. However, IPRs typically challenge patentability under 35 U.S.C. §§ 102 (novelty) and/or 103 (obviousness).
- Institution decision: Denied (discretionary denial). The precise date of the Director's decision is not explicitly available through general search, but the case was last modified on 2026-04-16. Given the filing date (2025-10-16), this decision falls under the USPTO's interim procedures established in March 2025, where the Director implemented a bifurcated approach to institution decisions focusing on discretionary considerations, including "settled expectations" and efficient workload management. The denial was likely based on such policy considerations rather than a determination on the merits of the challenged claims. Factors like the length of time the patent has been in force or the petitioner's prior knowledge of the patent (known as "settled expectations") frequently informed such discretionary denials during this period. [cite: 3, 9, 10 in the prior step]
- Final Written Decision (if issued): Not applicable, as institution was denied.
- Settlement / termination: Not applicable, as institution was denied; the proceeding did not reach a stage for settlement or termination on the merits.
- Appeal: Decisions to deny institution of an IPR are generally not appealable to the Federal Circuit.
- Defensive value: This proceeding indicates that the challenged claims of RE48479 were not subjected to a merits review by the PTAB and thus were neither invalidated nor confirmed as patentable in this context. While the patent owner prevailed in preventing a trial, the underlying patentability of the claims remains untested by the PTAB. The petitioner, Ontel Products Corporation et al., along with any real parties in interest or privies, may be estopped from raising the same or substantially similar invalidity grounds against RE48479 that were presented or could have been reasonably presented in this petition.
Strategic summary
All claims of RE48479 are currently UNTESTED by the PTAB on their merits. The single IPR proceeding filed against RE48479 (IPR2025-01536) resulted in a discretionary denial of institution, meaning the PTAB did not reach a decision on the patentability of the challenged claims. Therefore, no claims of RE48479 have been canceled or sustained by the PTAB.
The estoppel landscape for RE48479 is relatively clear for this specific proceeding. Under 35 U.S.C. § 315(e)(2), a petitioner (and its real parties in interest or privies) is generally estopped from asserting in a civil action or ITC investigation that a claim is invalid on any ground that the petitioner raised or reasonably could have raised during an IPR that results in a Final Written Decision. Since IPR2025-01536 was denied institution on discretionary grounds, rather than reaching a Final Written Decision, the full scope of statutory estoppel under § 315(e)(2) might not apply as broadly as it would after a full trial. However, the petitioner (Ontel Products Corporation et al.) and its privies would likely be precluded from filing another petition against RE48479 with the same or substantially similar grounds that were presented in IPR2025-01536, especially if the discretionary denial was based on factors related to the petition itself or the petitioner's conduct. New prior-art grounds or different legal theories (e.g., if the original petition only asserted §102 grounds, §103 grounds might still be available to new parties, or even the same party if it's a truly different set of claims/grounds that couldn't have been reasonably raised). For a defendant currently being asserted against (other than Ontel Products Corporation et al. and its privies), all prior-art grounds remain potentially available.
There is no pattern of multiple IPRs on this patent, nor is there any indication of aggressive PTAB appeals by the patent owner or involvement of a defensive aggregator.
Recommended next steps
Since the patent has not had any claims invalidated by the PTAB, the immediate defensive posture against assertion of RE48479 is that its patentability on the merits has not been judicially confirmed or denied by the PTAB.
For a defendant considering challenging this patent:
- Obtain the full claims and specification of RE48479: Access the full text of US Patent RE48479 via a dedicated USPTO patent search portal (e.g., Patent Public Search, Patent Center) to thoroughly understand the scope of the claims. General web searches have not yielded the complete, verifiable claim set.
- Review the institution decision for IPR2025-01536: If possible, obtain the Director's Decision for IPR2025-01536. Understanding the specific reasoning behind the discretionary denial (e.g., Fintiv factors, "settled expectations," or other policy grounds) will be crucial. This document would detail why the PTAB chose not to institute, which informs potential future challenges and estoppel arguments.
- Consider a new IPR petition: If you are not in privity with Ontel Products Corporation et al., or if you have strong new grounds of unpatentability or can distinguish your petition from the previous denial, an IPR remains a viable option. Careful consideration of the USPTO's current discretionary denial policies, especially concerning Fintiv factors and "settled expectations," will be essential when drafting any new petition.
- No active proceedings are pending. The absence of further PTAB activity on this patent means that there are no upcoming trial-stage milestones (e.g., institution decision deadline, oral hearing, FWD due date) to monitor.
Generated 6/15/2026, 12:47:40 AM